Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Determine when to stay invested versus selling SP 500 in retirement with a simple framework that prioritizes risk control and income needs.
19,407 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Thinking about turning a solid investment into a multi-bagger? This guide outlines five stock ideas with the potentia...
Polunsky Beitel Green expands its Dallas-based business development team with Jeanine LaMay Kay, signaling a broader ...
The XRP Ledger reached 8 million activated accounts, a milestone underscoring growing on-chain adoption as the market...
After the latest earnings, investors are weighing growth prospects, margins, and valuation for Domino's. This guide b...
NVIDIA is broadening beyond GPUs into physical AI robotics, building a global ecosystem and securing China sales, as ...
A mid-cap tech stock has quietly outperformed NVIDIA on a three-year price-return basis, triggering renewed interest ...
A prominent investor takes a sizable stake in BrightSpring Health Services, sparking renewed attention on BTSG stock....
A notable investment firm expanded its Sonos position just as the company prepares a fresh product lineup. This move ...
Bitcoin on-chain signals from Glassnode show a shift toward loss-dominant selling, with key metrics dipping below bea...
Salesforce heads into a pivotal Q4 showing whether Agentforce can convert hype into durable revenue. A strong read co...
Dell Technologies beat Q4 expectations and raised FY27 guidance, underscoring the surge in AI-optimized servers. As i...